Discover
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
3.40
2 x 2.45
2 x 4.00
bid
ask
+
0.15
4.62%
2 @ 07:39 AM
3.49 +0.09 (2.65%)
| Ytd | -81.11% | |
| 1y | -92.17% |
3.05
day range
3.49
2.90
52 week range
55.90
| Open | 3.16 | Prev Close | 3.25 | Low | 3.05 | High | 3.49 | Mkt Cap | 1.99M |
| Vol | 166.10K | Avg Vol | 845.98K | EPS | 0.10 | P/E | 34.00 | Forward P/E | N/A |
| Beta | 0.74 | Short Ratio | 0.25 | Inst. Own | 1.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.05 | 200-d Avg | 16.79 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.22M | ||
| Research and Development Expense | 267.24K | ||
| Selling, General and Administrative Expense | 1.95M | ||
| Operating Income | -2.22M | ||
| Interest Expense | 12.12K | ||
| Net Income | -2.15M | ||
| Net Income Common Stock | -2.15M | ||
| Net Income Common Stock (USD) | -2.15M | ||
| Consolidated Income | -2.15M | ||
| Earnings per Basic Share | -4.30 | ||
| Earnings per Basic Share (USD) | -4.30 | ||
| Earnings per Diluted Share | -4.30 | ||
| Earning Before Interest & Taxes (EBIT) | -2.14M | ||
| Earning Before Interest & Taxes (USD) | -2.14M | ||
| Weighted Average Shares | 503.16K | ||
| Weighted Average Shares Diluted | 503.16K | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.09M | ||
| Cash and Equivalents (USD) | 1.09M | ||
| Current Assets | 2.46M | ||
| Property, Plant & Equipment Net | 101.46K | ||
| Total Assets | 11.81M | ||
| Debt Current | 79.96K | ||
| Total Debt | 214.01K | ||
| Current Liabilities | 8.31M | ||
| Debt Non-Current | 134.05K | ||
| Total Liabilities | 8.46M | ||
| Accumulated Retained Earnings (Deficit) | -48.45M | ||
| Shareholders Equity | 3.35M | ||
| Shareholders Equity (USD) | 3.35M | ||
| Assets Non-Current | 9.35M | ||
| Total Debt (USD) | 214.01K | ||
| Goodwill and Intangible Assets | 9.24M | ||
| Liabilities Non-Current | 157.47K | ||
| Trade and Non-Trade Payables | 1.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 633.34K | ||
| Net Cash Flow from Financing | 3.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 755.94K | ||
| Capital Expenditure | -36.00K | ||
| Issuance (Purchase) of Equity Shares | 3.21M | ||
| Net Cash Flow from Investing | -36.00K | ||
| Net Cash Flow from Operations | -2.42M | ||
| Share Based Compensation | 35.02K | ||